SCHEMBL17174285

SCHEMBL17174285

COc1cc(OC(C)(C)C)ccc1-c1c(C)ccnc1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.37
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ADORA1 P30542 2/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ DRD1 P21728 3/20 0.35
▸ GAA P10253 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ G6PC1 P35575 1/20 0.34
▸ AR P10275 1/20 0.34
▸ POLQ O75417 1/20 0.34
▸ USP8 P40818 2/20 0.33
▸ XDH P47989 1/20 0.33
▸ HASPIN Q8TF76 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SIK1 P57059 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15698831 0.89 EGFR (0.45) EGFRCYP1A1CYP1B1ALDH1A1ADORA1
SCHEMBL17174385 0.88 DRD1 (0.43) DRD1HASPIN
SCHEMBL20392937 0.83 CRHR1 (0.38) EGFRCYP1A1CYP1B1ALDH1A1ADORA1
SCHEMBL19390775 0.80 ESR1 (0.40) ALDH1A1ADORA1ADORA2AGAAKMT2A
SCHEMBL17178242 0.78 DRD1 (0.46) ALDH1A1DRD1KMT2AMAPTUSP8
SCHEMBL19371622 0.76 DRD1 (0.54) DRD1
SCHEMBL15705511 0.74 DRD1 (0.50) CYP1A1CYP1B1DRD1KMT2AMEN1
SCHEMBL15698821 0.73 DRD1 (0.46) DRD1
SCHEMBL15705497 0.72 DRD1 (0.55) DRD1HASPIN
SCHEMBL17174359 0.70 DRD1 (0.40) CYP1A1CYP1B1ALDH1A1DRD1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180200253-A1 Heteroaromatic Compounds and their Use as Dopamine D1 Ligands PFIZER INC. (US) 2018-07-19 — — US disclosed
US-20170165270-A1 Heteroaromatic Compounds and their Use as Dopamine D1 Ligands PFIZER INC. (US) 2017-06-15 — — US disclosed
US-20170165270-A1 Heteroaromatic Compounds and their Use as Dopamine D1 Ligands PFIZER INC. (US) 2017-06-15 — — US disclosed
US-9617275-B2 Heteroaromatic compounds and their use as dopamine D1 ligands PFIZER INC. (US) 2017-04-11 — — US disclosed
US-9617275-B2 Heteroaromatic compounds and their use as dopamine D1 ligands PFIZER INC. (US) 2017-04-11 — — US disclosed
US-20150291625-A1 Heteroaromatic Compounds and their Use as Dopamine D1 Ligands PFIZER (US) 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180200253-A1 Heteroaromatic Compounds and their Use as Dopamine D1 Ligands COMT, DRD2, NR3C1 EGFR 3579/4885CYP1A1 512/4885CYP1B1 734/4885
US-20150291625-A1 Heteroaromatic Compounds and their Use as Dopamine D1 Ligands ARRB1, ADRA1D, ADRB1 EGFR 2712/4885CYP1A1 203/4885CYP1B1 280/4885
US-20170165270-A1 Heteroaromatic Compounds and their Use as Dopamine D1 Ligands ARRB1, DRD3, ADRB1 EGFR 3811/4885CYP1A1 742/4885CYP1B1 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback